Frequently asked questions
Does AI replace the diligence team?
No. It replaces the gathering step. Verdicts, weighting, and the investment recommendation remain with the reviewer; the system supplies the structured evidence those decisions rest on.
How current is the underlying data?
Trials, filings, and publications are refreshed continuously, and each assessment records the date its evidence was pulled so a stale review is visible as stale.
Can it assess assets outside our therapeutic area?
Yes. The assessment structure is therapeutic-area agnostic; precedent selection is not, so cross-area assessments carry a lower confidence level until reviewed by an area specialist.
How long does an assessment take?
A first triage pass returns in minutes rather than weeks. Full diligence depth depends on how many open items the team chooses to close.
How does AI analysis compare with traditional methods?
| Area | Traditional method | AI-enabled outcomes |
|---|---|---|
| Indication selection | Manual synthesis of dozens of sources | Instant mapping of opportunity landscape |
| Portfolio review | Excel spreadsheets and gut instinct | Probabilistic scoring by success metrics |
| Diligence | Months of labor-intensive reviews | Real-time risk analysis |
Is our asset data used to train your models?
No. At no point is your proprietary information exposed or used to train publicly-available AI models. Your data is never sent to OpenAI, Anthropic or any other public AI provider, and we can agree custom data privacy restrictions. Vibe Bio’s own work product may be anonymized and aggregated for future benchmarking and reporting.
Who can see the assets we upload?
Access is scoped by role. A deal team sees its own assets and nothing else, and every access event is recorded in the audit trail.
Can we run this under an NDA?
Yes. NDA coverage is applied on request before any asset material is shared with the team or the platform.